BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31893313)

  • 21. Health-related quality of life, personality and choice of coping are related in renal cell carcinoma patients.
    Beisland E; Beisland C; Hjelle KM; Bakke A; Aarstad AK; Aarstad HJ
    Scand J Urol; 2015; 49(4):282-9. PubMed ID: 25515950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors contributing to psychological distress in the working population, with a special reference to gender difference.
    Viertiö S; Kiviruusu O; Piirtola M; Kaprio J; Korhonen T; Marttunen M; Suvisaari J
    BMC Public Health; 2021 Mar; 21(1):611. PubMed ID: 33781240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing Changes in Renal Function After Radical Surgery for Upper Tract Urothelial Carcinoma and Renal Cell Carcinoma.
    Singla N; Hutchinson R; Menegaz C; Haddad AQ; Jiang L; Sagalowsky AI; Cadeddu JA; Lotan Y; Margulis V
    Urology; 2016 Oct; 96():44-53. PubMed ID: 27443467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examination of Gender Differences in the Influence of Social Support on Psychological Distress in Canadian Adults with Bipolar Disorder.
    Warren CD; Fowler K
    Psychiatr Q; 2021 Sep; 92(3):1187-1199. PubMed ID: 33655396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.
    Schmitges J; Trinh QD; Sun M; Hansen J; Bianchi M; Jeldres C; Perrotte P; Dahlem R; Shariat SF; Chun FK; Montorsi F; Menon M; Fisch M; Graefen M; Karakiewicz PI
    BJU Int; 2012 Sep; 110(6 Pt B):E183-90. PubMed ID: 22321256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytoreductive radiofrequency ablation in patients with metastatic renal cell carcinoma (RCC) with small primary tumours treated with sunitinib or interferon-α.
    Tsimafeyeu I; Zart JS; Chung B
    BJU Int; 2013 Jul; 112(1):32-8. PubMed ID: 23746142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-operative acute kidney injury in patients with renal cell carcinoma is a potent risk factor for new-onset chronic kidney disease after radical nephrectomy.
    Cho A; Lee JE; Kwon GY; Huh W; Lee HM; Kim YG; Kim DJ; Oh HY; Choi HY
    Nephrol Dial Transplant; 2011 Nov; 26(11):3496-501. PubMed ID: 21406544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of Life and Psychological Distress among Patients with Small Renal Masses.
    Vartolomei L; Cotruș A; Stanciu C; Delcea C; Tozzi M; Lievore E; Crocetto F; Del Giudice F; Lucarelli G; Muto M; Ferro M
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pilot study of the effects of expressive writing on psychological and behavioral adjustment in patients enrolled in a Phase II trial of vaccine therapy for metastatic renal cell carcinoma.
    de Moor C; Sterner J; Hall M; Warneke C; Gilani Z; Amato R; Cohen L
    Health Psychol; 2002 Nov; 21(6):615-9. PubMed ID: 12433015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of locally advanced and metastatic disease in patients with small renal masses.
    Kates M; Korets R; Sadeghi N; Pierorazio PM; McKiernan JM
    BJU Int; 2012 May; 109(10):1463-7. PubMed ID: 21933329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of beta-blockers and survival among hypertensive patients with renal cell carcinoma.
    Parker WP; Lohse CM; Zaid HB; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Urol Oncol; 2017 Jan; 35(1):36.e1-36.e6. PubMed ID: 27687543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a Risk-stratified Approach for Follow-up Imaging After Percutaneous Thermal Ablation of Sporadic Stage One Renal Cell Carcinoma.
    Dreyfuss LD; Wells SA; Best SL; Hedican SP; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Nakada SY; Abel EJ
    Urology; 2019 Dec; 134():148-153. PubMed ID: 31465794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trajectories of physical symptom burden and psychological distress during the last year of life in patients with a solid metastatic cancer.
    Shafiq M; Malhotra R; Teo I; Ozdemir S; Kanesvaran R; Malhotra C;
    Psychooncology; 2022 Jan; 31(1):139-147. PubMed ID: 34432911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of IL-2 immunotherapy in metastatic renal cell carcinoma in relation to the psychic profile as evaluated using the Rorschach test.
    Messina G; Lissoni P; Bartolacelli E; Fumagalli L; Brivio F; Colombo E; Gardani GS
    Anticancer Res; 2007; 27(4C):2985-8. PubMed ID: 17695482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concurrent renal cell carcinoma and urothelial carcinoma: long-term follow-up study of 27 cases.
    Qi N; Chen Y; Gong K; Li H
    World J Surg Oncol; 2018 Jan; 16(1):16. PubMed ID: 29370814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of the Edmonton Symptom Assessment System for Symptom Distress Screening at a Community Cancer Center: A Pilot Program.
    Hui D; Titus A; Curtis T; Ho-Nguyen VT; Frederickson D; Wray C; Granville T; Bruera E; McKee DK; Rieber A
    Oncologist; 2017 Aug; 22(8):995-1001. PubMed ID: 28476945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
    Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
    J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Commentary on "Cytoreductive radiofrequency ablation in patients with metastatic renal cell carcinoma (RCC) with small primary tumours treated with sunitinib or interferon-α." Tsimafeyeu I, Zart JS, Chung B, Kidney Cancer Research Bureau, Moscow, Russian Federation.: BJU Int 2013; 112(1):32-8. [Epub 2013 Jun 7]. doi: 10.1111/bju.12107.
    Boorjian S
    Urol Oncol; 2014 May; 32(4):514-5. PubMed ID: 24767689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.